BMD Clinical Trial
Official title:
Nutrition Status, Bone Mass Density, and Selective Serotonin Reuptake Inhibitors
The association between selective serotonin reuptake inhibitor (SSRI) use and bone mass density (BMD) has been debated. Some have suggested features of depression, which SSRIs are prescribed to treat, may be a cause of decreased BMD, such as poor overall food intake at the time of SSRI use. Our study seeks to determine whether SSRI use in adults is associated with lower than average BMD, and if there is an association between low micronutrient intake, SSRI use, and a low BMD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05704088 -
SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients
|
Phase 4 | |
| Completed |
NCT03820895 -
Vitamin D Levels in Adolescent Idiopathic Scoliosis
|
||
| Completed |
NCT00472745 -
The Effect of Weight Loss on Bone in Men
|
N/A | |
| Recruiting |
NCT05102916 -
Swiss Registry for Neuromuscular Disorders
|
||
| Completed |
NCT03866135 -
Bone Mineral Density, Disease Duration, and Activity in Ankylosing Spondylitis
|
||
| Recruiting |
NCT03225703 -
The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women
|
N/A | |
| Completed |
NCT04427644 -
Body Mass Index and Obesity Surgery Mortality Risk Score in Perioperative Complications of Laparoscopic Sleeve Gastrectomy
|
||
| Withdrawn |
NCT05457530 -
Doravirine and Weight Gain in Antiretroviral Naive
|
Phase 3 |